-+ 0.00%
-+ 0.00%
-+ 0.00%

TD Cowen Downgrades Cardiff Oncology to Hold

Benzinga·06/01/2026 14:40:28
Listen to the news
TD Cowen analyst Marc Frahm downgrades Cardiff Oncology (NASDAQ:CRDF) from Buy to Hold.